litigation

News

Packaged Pills in aluminium blisters stacked on each other

Purdue bankruptcy court hands immunity to Sackler family

A US federal judge has approved a bankruptcy settlement for Purdue Pharma that grants the Sackler family that owned the business immunity from any further civil lawsuits accusing them of co

News

Appeals court reverses $1.2bn judgment against Gilead in BMS...

Gilead Sciences' Kite Pharma has won a key victory on appeal in its long-running dispute with Bristol Myers Squibb over patents relating to CAR-T therapies, overturning a $1.2 billion fine

News

Tablets on dollar bills (treatment, addiction, aging - concept). Vintage effect.

Years after Pfizer merger, ex-Medivation exec gets insider t...

A Medivation executive at the heart of the company's team that sold the company to Pfizer for $14 billion five years ago is facing allegations of insider trading.

News

FTC drops AbbVie antitrust case, but fires a parting shot at...

AbbVie will not be pursued any further by the US government over allegations that it used 'sham' litigation to keep competition to its AndroGel testosterone replacement product off the mark

News

Martin Shkreli's $7.4m forfeit is paid, thanks to that Wu-Ta...

The US government has sold off the one-of-a-kind Wu-Tang Clan album famously bought by 'pharma bro' Martin Shkreli, with the proceeds enough to wipe out his $7.4 million fine for defrauding

News

Is J&J nearing the end of its opioid liability hangover?

Johnson & Johnson and the 'big three' US pharma wholesalers are on the brink of a $26 billion settlement deal covering thousands of lawsuits alleging their involvement in contributing t

Purdue bankruptcy court hands immunity to Sackler family

Appeals court reverses $1.2bn judgment against Gilead in BMS...

Years after Pfizer merger, ex-Medivation exec gets insider t...

FTC drops AbbVie antitrust case, but fires a parting shot at...

Martin Shkreli's $7.4m forfeit is paid, thanks to that Wu-Ta...

Is J&J nearing the end of its opioid liability hangover?

Ambrosia's sweet $100m round, and other biofinancings

Using AI-driven synthetic personas to take your insights fur...

litigation

Editor's Picks